American Portfolios Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding SBIO
RJFSA
NAM
BPA
SFS
AC
American Portfolios Advisors's SBIO Position: Q3 2022 in Review
American Portfolios Advisors increased its ALPS Medical Breakthroughs ETF (SBIO) stake by 1,412% in Q3 2022, buying an estimated $153K and bringing the position to 5,170 shares worth $156K. The position accounts for 0.01% of the portfolio, ranked #1128.
American Portfolios Advisors first reported a position in SBIO in Q4 2017 and has held it in 20 quarters since. The position peaked at $195K in Q2 2018. 44 funds tracked by Wall St. Rank hold SBIO as of Q3 2022.
- American Portfolios Advisors held 5,170 shares of ALPS Medical Breakthroughs ETF worth $156K as of Q3 2022.
- American Portfolios Advisors bought 4,828 ALPS Medical Breakthroughs ETF shares in Q3 2022, an estimated $153K.
- ALPS Medical Breakthroughs ETF made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1128 holding.
- American Portfolios Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2017 and has held it in 20 quarters since.
- American Portfolios Advisors's ALPS Medical Breakthroughs ETF position peaked at $195K in Q2 2018.
- 44 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.